Suppr超能文献

伊朗北部肺结核患者的治疗延迟和总延迟情况:应用生存数据分析

Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis.

作者信息

Yazdani-Charati Jamshid, Rezai Mohammad Sadegh, Fendereski Afsane, Mohammadi Soraya, Alipour Nadia

机构信息

Department of Biostatistics, Health Sciences Research Center, School of Health Sciences, Mazandaran University of Medical Sciences, Sari, Iran.

Infectious Disease Research Center with Focus on Nosocomial Infections, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Tanaffos. 2017;16(1):13-21.

Abstract

BACKGROUND

Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. Identifying the factors associated with the treatment delay and total delay would be helpful in the prevention of tuberculosis and in reducing the burden on the health care system. The objective of this study was to assess the treatment delay and total delay in TB patients and investigate the factors causing these delays.

MATERIALS AND METHODS

This was a longitudinal study conducted in 2009-2015. Our study consisted of 1694 TB patients registered in the TB center of Mazandaran province. Data regarding the patients' demographic characteristics and clinical factors associated with treatment delay and total delay were analyzed. Kaplan Meier plots and log rank tests were used to assess the survival pattern. Cox proportional hazards model for multivariable analysis was discussed. We used mean values and median (Q2) [first quartile (Q1)-third quartile (Q3)] to describe delays.

RESULTS

The median treatment delay and total delay were 35 (ranged 23-80) and 36 (ranged 24-82) days, respectively. The mean age of TB patients was 47.40±20.3. No significant association was found between the location of residence, nationality, gender, and type of pulmonary TB patients with treatment delay and total delay. Additionally, age, prison status of patients, HIV test, and contact history had a significant relationship with the treatment delay and total delay (p-value <0.05). It was shown that the median total delay in men patients in the ≤14 year-old age group, imprisoner patients, rural patients, patients who have not received an HIV test, smear negative patients, those who are Iranian, and TB patients whose contact history was unknown was lower than that of others. The highest median treatment delay and total delay was in the >60 age groups, and were 41 and 44 days, respectively. Treatment delay was the same as the total delay except in the place of residence variable; median treatment delay among urban patients was less than that of rural patients.

CONCLUSION

According to this study age, prison status of patients, HIV test and contact history had a significant relationship with the treatment delay and total delay (P-value<0.05). Understanding the factors that are closely associated with these delays is essential to effectively control TB and could be helpful in reducing these delays.

摘要

背景

结核病仍是全球传染病死亡的主要原因。确定与治疗延迟和总延迟相关的因素,将有助于预防结核病并减轻医疗保健系统的负担。本研究的目的是评估结核病患者的治疗延迟和总延迟情况,并调查导致这些延迟的因素。

材料与方法

这是一项于2009年至2015年进行的纵向研究。我们的研究包括在马赞德兰省结核病中心登记的1694例结核病患者。分析了患者的人口统计学特征以及与治疗延迟和总延迟相关的临床因素。采用Kaplan Meier曲线和对数秩检验来评估生存模式。讨论了用于多变量分析的Cox比例风险模型。我们使用平均值和中位数(Q2)[第一四分位数(Q1) - 第三四分位数(Q3)]来描述延迟情况。

结果

治疗延迟和总延迟的中位数分别为35天(范围23 - 80天)和36天(范围24 - 82天)。结核病患者的平均年龄为47.40±20.3岁。居住地点、国籍、性别和肺结核患者类型与治疗延迟和总延迟之间未发现显著关联。此外,年龄、患者的监狱服刑状况、HIV检测和接触史与治疗延迟和总延迟有显著关系(p值<0.05)。结果显示,年龄≤14岁的男性患者、服刑人员、农村患者、未接受HIV检测的患者、涂片阴性患者、伊朗籍患者以及接触史不明的结核病患者的总延迟中位数低于其他患者。治疗延迟和总延迟中位数最高的是年龄>60岁的组,分别为41天和44天。除居住地点变量外,治疗延迟与总延迟相同;城市患者的治疗延迟中位数低于农村患者。

结论

根据本研究,年龄、患者的监狱服刑状况、HIV检测和接触史与治疗延迟和总延迟有显著关系(P值<0.05)。了解与这些延迟密切相关的因素对于有效控制结核病至关重要,并且有助于减少这些延迟。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b9a/5473378/52dfc73000d7/Tanaffos-16-13-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验